
MENA Metabolic and Obesity Conference (MMOC)
Obesity is one of the most pressing and complex health challenges of our time—yet its diagnosis and treatment remain inconsistently addressed across medical specialties. This conference brings together leading voices in medicine to close that gap.
Designed to promote collaboration across disciplines, this program offers a deep dive into the full spectrum of obesity care—from early identification and lifestyle interventions to advanced pharmacologic and surgical treatments. Participants will gain access to the latest evidence, innovations, and tools to navigate the evolving landscape of obesity and its metabolic complications.
Join us as we move beyond fragmented care and toward a unified, patient-centered approach to tackling obesity in the MENA region and beyond.
Target Audience
- Anesthesiologists
- Bariatric Surgeons
- Cardiologists
- Clinical Psychologists and Physiatrists
- Dietitians / Nutritionists
- Endocrinologists
- Family Medicine Physicians / Internal Medicine Physicians
- Gynecologists
- Hepatologists and Gastroenterologists
- Internal Medicine Physicians
- Nephrologists
- Neurologists
- Nurses / Nurse Practitioners
- Obesity medicine Physicians
- Oncologists
- Pharmacists
- Pulmonologists and Sleep medicine Specialists
- Rheumatologists
- Urologists
Learning Objectives
By the end of this conference, participants will be able to:
- Understand the Global Burden of Obesity: Explore obesity as a global health crisis and the need for integrated, multidisciplinary care.
- Review Treatment Strategies: Highlight current and evolving medical and surgical options, including evidence-based guidelines.
- Link Obesity with Cardiometabolic Risk: Examine how obesity contributes to cardiometabolic disease and its management.
- Explore Innovation and Precision Medicine: Introduce emerging tools such as wearables and personalized treatment approaches.
- Emphasize Lifestyle-Based Care: Underscore the lasting impact of nutrition, activity, and behavioral change in obesity management.
Additional Information
Attachment | Size |
---|---|
![]() | 4.05 MB |

Venue is located in Cleveland Clinic Abu Dhabi, Level P1 , Auditorium.
The planning committee, faculty and others in control of content (either individually or as a group) do not have relevant financial relationships with ineligible companies.
Carlos Abril Vega, MD, PhD, FACS, FASMBS
Maguy Chiha, MD
Javed Raza, MBBS, FRCS
John Rodriguez, MD
Cynthia Salloum, MD
Safa Botros Hegazin, MD, FACP, NCMP
Mohammed Al Hadad, MBChB, FRCSI, FRCS Glasg, FACS
Sara Suliman, MBBS, DPhil (Oxon), FRCP
Sulieman Abdal Raheem, MD
Lubna Alhourani, MD
Yazan Aljabery, Ass. Professor, MD
Alaeddin Barham
Camilo Boza, MD FACS FASMBS
W Scott Butsch, MD MSc
Naser Gharaibeh, Naser Gharaibeh
Rahat Ghazanfar
Muriel Ghosn
Daniel Guerron, MD
Ghina Hamaoui, MSHA, RD
Mohammad Jamal, MBChB(Hons) MEd FRCSC DABS FASMBS FAOM
Brad Moore, MD, MPH, FACP, Dip.ABLM
Juan Pablo Pantoja, MD
Ronney Shantouf, MD
Available Credit
- 8.00 AMA PRA Category 1 Credit™
Cleveland Clinic Abu Dhabi is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Cleveland Clinic Abu Dhabi designates this Live activity for a maximum of 8.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Diamond Sponsor
L-Nutra is the leader in longevity and nutrition science, pioneering clinically tested innovations that use food to support healthy aging, improve metabolic outcomes, and extend human healthspan. With over 130 patents and 47+ clinical trials conducted in partnership with 18 global research institutions, L-Nutra’s portfolio includes Prolon®️ consumer products and comprehensive clinical programs offered through its medical division, L-Nutra Health. Its medical programs are designed to help reverse the severity of metabolic conditions—such as obesity and type 2 diabetes—by combining patented nutrition protocols with personalized lifestyle medicine. L-Nutra’s work unlocks the technology in nutrition to reduce biological age, support cellular rejuvenation, and empower millions to live better, longer lives. Learn more at www.l-nutra.com & www.prolon.ae
Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable.
Novo Nordisk is a global healthcare company with over a century of innovation and leadership in diabetes care. Headquartered in Denmark, the company drives change to defeat serious chronic diseases such as diabetes, obesity, rare blood, and endocrine disorders. With a strong commitment to advancing science and improving patient outcomes, Novo Nordisk develops innovative medicines and delivery systems that impact millions of lives worldwide.
Operating in more than 80 countries and reaching patients in over 170 markets, Novo Nordisk integrates sustainability into every aspect of its business — from research and manufacturing to access and education — striving to build a healthier world for future generations.
Gold Sponsor
Applied Medical is a next-generation medical device company committed to improving global access to high-quality care. Applied Medical
They operate under a vertically integrated model—designing, developing, and manufacturing products in house—which enables innovation, tighter quality control, and responsive customer support.
Their clinical education programs reinforce their mission, offering courses, symposia, and simulation training focused on minimally invasive techniques across a wide range of surgical specialties.
Silver Sponsor
A distinguished regional leader in the distribution and commercialization of advanced Pharma ,medical and surgical technologies.
Operating across the UAE, Egypt, and Kenya, we connect world-class manufacturers from North America, Europe,
and Asia with dynamic healthcare markets in the Middle East and Africa.
To visit Arabco webpage, please click the link.
VIVUS is a biopharmaceutical company committed to advancing innovative clinical therapies. With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. We are a focused organization with expertise and insights to advance innovative new therapies.
Through its partnership with PharmaAccess, VIVUS can streamline operations in the GCC region, effectively reaching healthcare providers and patients, particularly with the availability of Qsymia® in the UAE. PharmaAccess provides VIVUS with fully integrated solutions, managing essential functions in Marketing, Sales and Distribution, Regulatory, Medical, and Pharmacovigilance.
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive, and solutions are personal. Johnson & Johnson has made significant contributions to surgery for more than 100 years, from creating the first sutures, to revolutionizing surgery with minimally invasive procedures. Our surgical technologies and solutions include sutures, staplers, energy devices, trocars and hemostats along with interventional ablation, robotics, and digital solutions…
We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary